Heart Failure, Systolic
126
16
21
51
Key Insights
Highlights
Success Rate
81% trial completion
Research Maturity
51 completed trials (40% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.5%
12 terminated out of 126 trials
81.0%
-5.6% vs benchmark
14%
18 trials in Phase 3/4
14%
7 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 51 completed trials
Clinical Trials (126)
A Study of LY3971297 in Participants With Heart Failure
AB-1002 in Patients With Class III Heart Failure
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management
Pharmacist-Assisted Titration of Rx to Implement Optimal Medical Therapy for Heart Failure
Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany
Paced Heart Rate Acceleration for Cardiac Conditioning
Hypoxic Conditioning in Heart Failure
Pilot Study Lp299v Supplementation in Chronic Heart Failure
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Effects of CRT Optimization as Assessed by Cardiac MR
Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App)
Digital Remote Home Monitoring for Heart Failure
Cardiac Performance During Steep Trendelenburg Position in Patients Undergoing Robotic Surgery Surgery.
Predicting Heart Failure Outcomes With Biomarkers and Imaging
Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status
Physiological Effects of Lactate in Individuals With Chronic Heart Failure
Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells
Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure
CardiAMP™ Cell Therapy for Heart Failure Trial